Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05398315 · ClinicalTrials.gov registry record · NA

Interactive Alcohol Decision-Making Programs

A NA study of Heavy Drinking, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
352
Enrollment target
1
Study location

NCT05398315: Completed NA study of Heavy Drinking, sponsored by Wayne State University.

NCT05398315 is a NA study of Heavy Drinking that has completed, run by Wayne State University. The registered enrollment target is 352 participants, above the 311-participant average among 9 other Heavy Drinking trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05398315, a NA study of Heavy Drinking, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
352 participants
Enrollment target
1
Study location

Study Summary

This project aims to develop a maximally effective, computer-delivered brief intervention (CDBI) for reducing heavy alcohol use. More specifically, the investigators will examine outcomes of different versions of a CDBI in which the presence/absence of empathic statements, the gender of the narrator, the presence/absence of a narrator backstory, and the use/non-use of motivational interviewing techniques are systematically manipulated using a factorial design. Participants (352 heavy drinkers) will be randomly assigned to 1 of 16 intervention conditions, representing all combinations of the 4 variables being manipulated. The investigators hypothesize that there will be significant main effects of all four factors being manipulated on (a) subjective reactions to the CDBI and (b) alcohol outcomes at 1-month follow-up

Primary Outcome

The Timeline Followback Questionnaire (TLFB) will be given to assess past month alcohol use.

Conditions Studied

Interventions

  • BEHAVIORAL Empathic Statements/Reflections
  • BEHAVIORAL Narrator Backstory
  • BEHAVIORAL Male Narrator
  • BEHAVIORAL Female Narrator
  • BEHAVIORAL MI Techniques

Study Locations (1)

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 352 participants
Start Date 2021-07-01
Est. Completion 2023-04-01
Phase NA
Wayne State University

163 total trials

What the finished NCT05398315 record still lists

NCT05398315 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, above the 311-participant average among 9 other Heavy Drinking trials with a reported enrollment target (13% higher).

The record links to 1 condition, with Heavy Drinking appearing as the primary indexed condition, and to 5 interventions - of which Empathic Statements/Reflections is the first listed.

NCT05398315 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05398315 about?

NCT05398315 is a clinical study titled "Interactive Alcohol Decision-Making Programs". This project aims to develop a maximally effective, computer-delivered brief intervention (CDBI) for reducing heavy alcohol use. More specifically, the investigators will examine outcomes of different versions of a CDBI in which the presence/absence of empathic statements, the gender of the narrator...

What is the current status of trial NCT05398315?

This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2021-07-01. Estimated completion is 2023-04-01.

What conditions does trial NCT05398315 study?

This clinical trial studies the following conditions: Heavy Drinking.

What interventions are being tested in trial NCT05398315?

The interventions under investigation include: Empathic Statements/Reflections (BEHAVIORAL), Narrator Backstory (BEHAVIORAL), Male Narrator (BEHAVIORAL), Female Narrator (BEHAVIORAL), MI Techniques (BEHAVIORAL).

Who is sponsoring clinical trial NCT05398315?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05398315 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heavy Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05398315's enrollment target sits among peer trials

352 5th of 9 higher than 5 of 9 other Heavy Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heavy Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05811936 · 352 participants · NA

    The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

  • NCT06258941 · 352 participants · Phase 1

    Classroom Break, Cognition, and Fitness in Elementary School Children

  • NCT06269081 · 352 participants · NA

    Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

  • NCT06337292 · 352 participants · Phase 3

    Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05398315, the US trial registry maintained by the National Library of Medicine. NCT05398315 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.